New York, December 2021: Axiom Market Research & Consulting™ added a report on point of care infectious disease market which includes study on disease, application, end user, and geography. Point of Care Infectious Disease Market was projected to grow at a CAGR of 8.27% for the forecast period 2021 to 2027. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the point of care infectious disease market.

The factors such as high demand for the portable and rapid testing devices as the point of care portable device can perform the blood analysis that can further enable the physician for making the decision for treatment while diagnosing, along with growing adoption in hospitals, diagnostic laboratories and home care settings across the world, increasing incidence and prevalence rates of the communicable diseases has been responsible for driving the growth of the point of care infectious disease testing market during the forecast period. 

The report analyses the point of care infectious disease testing market based on disease, application, end user, and geography. By disease, the point of care infectious disease testing market is segmented into hiv poc, clostridium difficile poc, hbv poc, hcv poc, hpv poc, hsv (herpes simplex virus) poc, influenza/flu poc, mrsa poc, pneumonia or streptococcus associated infections, respiratory syncytial virus (rsv) poc, tb and drug-resistant tb poc. By application, the point of care infectious disease testing market is segmented into during pregnancy and outside pregnancy. By end user, the point of care infectious disease testing market is segmented into hospitals, diagnostic laboratories, and home care settings. Geographically, the point of care infectious disease testing market is studied for the regions including North America Europe, Asia Pacific, and Rest of the World. 

HIV POC is expected to dominate the point of care infectious disease testing market

The factors such as increasing testing that is allowing the patient to test for the HIV and also receive the results at the same time has been driving the growth of the segment in the point of care infectious disease testing market during the forecast period. The testing also helps for the HIV that is having unprocessed specimens that can detect HIV infections with high sensitivity and specificity. 

During pregnancy application segment is anticipated to have high market share in the point of care infectious disease testing market

The during pregnancy testing application has the potential for enhancing the strategies for preventing the mother to transmit the HIV infection to the child, and this rapid testing also helps to decrease the laboratory infrastructure and should be performed by the health workers driving the growth of the segment in the point of care infectious disease testing market during the forecast period.

Hospitals end user segment is expected to gain high market share in the point of care infectious disease testing market

The increasing use of the point of care infectious disease testing in the hospitals as the testing has been a simple medical test that can be performed beside the patient, and it also provides an easy way for the physicians and patients for conducting the tests and helping the physicians to manage the patients driving the growth of the segment in the market during the forecast period.

North America is expected to dominate the point of care infectious disease testing market

The factors such as increasing demand for the market from the different end use industry, developed healthcare infrastructure and adoption of the point of care infectious disease testing has been propelling the growth of the point of care infectious disease testing market in the region of North America. 

Key Players 

The key players in the market are Beckman Coulter, Inc., Abbott Laboratories, Becton Dickinson Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Cardinal Health, Cepheid, Chembio Diagnostics Systems, Inc, Danaher, Gene POC, Hoffmann-La Roche Ltd, OJ-Bio Ltd, Ortho Clinical Diagnostics, Quest Diagnostics Inc., Siemens Healthineers, Sight Diagnostics Ltd, Thermo Fisher Scientific, Inc., Trinity Biotech and Trivitron Healthcare among others.  

Browse for More Details: https://www.axiommrc.com/product/10564-point-of-care-infectious-disease-testing-market-report 

Contact Us:

Ganesh Sai

United States

3 Germay Dr.Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com